S. Seki et al., ANTIMETASTATIC EFFECT OF NK1(-CELLS ON EXPERIMENTAL HEMATOGENOUS TUMOR-METASTASES IN THE LIVER AND LUNGS OF MICE() T), Immunology, 92(4), 1997, pp. 561-566
Depletion of both natural killer 1.1(+) (NK1(+)) intermediate alpha be
ta T-cell receptor (int T) cells and NK cells by in vivo treatment wit
h anti-NK1 antibody greatly increased hepatic metastases of intravenou
sly injected EL4 cells as well as pulmonary metastases of 3LL cells in
C57BL/6 mice. However, depletion of NK cells alone by anti-asialo GM1
(AGM1) antibody treatment did not increase the metastases in either o
rgan. Interleukin-12 (IL-12) administration into mice induced strong c
ytotoxicities of NK cell-depleted liver and lung mononuclear cells (MN
C) comparable to those without NK-cell depletion and inhibited metasta
ses in either organ. In contrast, in both NK cell- and NK1(+) int T-ce
ll-depleted mice, IL-12 could not induce cytotoxic activity of liver a
nd lung MNC and metastases in both organs increased with or without IL
-12 treatment. These results confirmed the fact that NK1(+) int T cell
s are more potent antitumour effecters than NK cells against experimen
tal haematogenous tumour metastases.